Hepatitis Forums
Advanced Liver Disease Main Forums => Advanced Liver Disease => Topic started by: Hep Editors on November 06, 2019, 10:35:17 am
-
The use of cholesterol-lowering statin medications among people with hepatitis B virus (HBV) is independently associated with a lower risk of hepatocellular carcinoma (HCC), the most common form of liver cancer, Healio reports.
Publishing their findings in Hepatology, a research team led by Myung Ji Goh, MD, of Sungkyunkwan University School of Medicine in South Korea, analyzed data on 7,713 people with HBV, including 713 people who took statins and 7,000 who did not.
The cohort members were defined as using statins if they took at least 28 cumulative daily doses during the study’s follow-up period.
Read more...
https://www.hepmag.com/article/people-hep-b-statin-use-tied-reduced-liver-cancer-risk